OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Long-term outcomes of the global tuberculosis and COVID-19 co-infection cohort
Nicolás Casco, Alberto Levi Jorge, Domingo Palmero, et al.
European Respiratory Journal (2023) Vol. 62, Iss. 5, pp. 2300925-2300925
Open Access | Times Cited: 22
Nicolás Casco, Alberto Levi Jorge, Domingo Palmero, et al.
European Respiratory Journal (2023) Vol. 62, Iss. 5, pp. 2300925-2300925
Open Access | Times Cited: 22
Showing 22 citing articles:
Global, regional, and national age-specific progress towards the 2020 milestones of the WHO End TB Strategy: a systematic analysis for the Global Burden of Disease Study 2021
Jorge R Ledesma, Jianing Ma, Meixin Zhang, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 7, pp. 698-725
Open Access | Times Cited: 36
Jorge R Ledesma, Jianing Ma, Meixin Zhang, et al.
The Lancet Infectious Diseases (2024) Vol. 24, Iss. 7, pp. 698-725
Open Access | Times Cited: 36
World Tuberculosis Day 2024 theme “Yes! We can end TB” can be made a reality through concerted global efforts that advance detection, diagnosis, and treatment of tuberculosis infection and disease
Delia Goletti, Seif Al-Abri, Giovanni Battista Migliori, et al.
International Journal of Infectious Diseases (2024) Vol. 141, pp. 106993-106993
Open Access | Times Cited: 10
Delia Goletti, Seif Al-Abri, Giovanni Battista Migliori, et al.
International Journal of Infectious Diseases (2024) Vol. 141, pp. 106993-106993
Open Access | Times Cited: 10
COVID-19, tuberculosis, and HIV triad: a prospective observational study in ambulatory patients in Kenya, Uganda, and South Africa
Helena Huerga, Maëlenn Gouillou, Liesbet Ohler, et al.
PLOS Global Public Health (2025) Vol. 5, Iss. 4, pp. e0004471-e0004471
Open Access
Helena Huerga, Maëlenn Gouillou, Liesbet Ohler, et al.
PLOS Global Public Health (2025) Vol. 5, Iss. 4, pp. e0004471-e0004471
Open Access
Causality between coronavirus disease 2019 and tuberculosis: A two-sample Mendelian randomization study
Lei Wang, Chidao Chen, Peng Wang, et al.
Medicine (2025) Vol. 104, Iss. 17, pp. e41999-e41999
Open Access
Lei Wang, Chidao Chen, Peng Wang, et al.
Medicine (2025) Vol. 104, Iss. 17, pp. e41999-e41999
Open Access
Mycobacterium tuberculosis growth inhibition by peripheral blood mononuclear cells from household contacts is not affected by previous SARS-CoV-2 infection
Jane Shaw, Charlotte Christie Petersen, Andriëtte Hiemstra, et al.
(2025)
Closed Access
Jane Shaw, Charlotte Christie Petersen, Andriëtte Hiemstra, et al.
(2025)
Closed Access
Mycobacterium tuberculosis growth inhibition by peripheral blood mononuclear cells from household contacts is not affected by previous SARS-CoV-2 infection
Jane Shaw, Charlotte Christie Petersen, Andriëtte Hiemstra, et al.
(2025)
Closed Access
Jane Shaw, Charlotte Christie Petersen, Andriëtte Hiemstra, et al.
(2025)
Closed Access
Assessment of the impact of COVID-19 on tuberculosis care at a tertiary hospital: integrating lessons from COVID-19 learned
Norma A. Téllez-Navarrete, Jesús Romero-Tendilla, Alejandra Rodríguez Morales, et al.
Frontiers in Public Health (2025) Vol. 13
Open Access
Norma A. Téllez-Navarrete, Jesús Romero-Tendilla, Alejandra Rodríguez Morales, et al.
Frontiers in Public Health (2025) Vol. 13
Open Access
Protective interplay: Mycobacterium tuberculosis diminishes SARS-CoV-2 severity through innate immune priming
Brittany D. Williams, Debora Ferede, Hazem F. M. Abdelaal, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Brittany D. Williams, Debora Ferede, Hazem F. M. Abdelaal, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Suppressing Mycobacterium tuberculosis virulence and drug resistance by targeting Eis protein through computational drug discovery
Geethu S. Kumar, Amaresh Kumar Sahoo, Nishant Ranjan, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 2
Geethu S. Kumar, Amaresh Kumar Sahoo, Nishant Ranjan, et al.
Molecular Diversity (2024)
Closed Access | Times Cited: 2
Impact of Tuberculosis on Disease Severity and Viral Shedding Duration in COVID-19 Patients
Wei Huang, Ping Liu, Bo Yan, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 260-260
Open Access | Times Cited: 1
Wei Huang, Ping Liu, Bo Yan, et al.
Viruses (2024) Vol. 16, Iss. 2, pp. 260-260
Open Access | Times Cited: 1
Operational research as a mechanism to improve treatment outcomes for drug-resistant TB in the WHO European Region
Giovanni Battista Migliori, Oleksandr Korotych, Jay Achar, et al.
Deleted Journal (2024) Vol. 1, Iss. 3, pp. 103-110
Open Access | Times Cited: 1
Giovanni Battista Migliori, Oleksandr Korotych, Jay Achar, et al.
Deleted Journal (2024) Vol. 1, Iss. 3, pp. 103-110
Open Access | Times Cited: 1
Augmenting Radiological Diagnostics with AI for Tuberculosis and COVID-19 Disease Detection: Deep Learning Detection of Chest Radiographs
Manjur Kolhar, Ahmed M. Al Rajeh, Raisa Nazir Ahmed Kazi
Diagnostics (2024) Vol. 14, Iss. 13, pp. 1334-1334
Open Access | Times Cited: 1
Manjur Kolhar, Ahmed M. Al Rajeh, Raisa Nazir Ahmed Kazi
Diagnostics (2024) Vol. 14, Iss. 13, pp. 1334-1334
Open Access | Times Cited: 1
Doenças Infecciosas e Parasitárias - Edição XIII
Guilherme Barroso Langoni de Freitas, Gabriela Rodrigues Gabriel, Gustavo Bastos Criscuolo, et al.
(2024)
Open Access | Times Cited: 1
Guilherme Barroso Langoni de Freitas, Gabriela Rodrigues Gabriel, Gustavo Bastos Criscuolo, et al.
(2024)
Open Access | Times Cited: 1
The effect of previous SARS-CoV-2 infection on systemic immune responses in individuals with tuberculosis
Mariana Simão Xavier, Mariana Araújo‐Pereira, Quezia M. de Oliveira, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Mariana Simão Xavier, Mariana Araújo‐Pereira, Quezia M. de Oliveira, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Long-term outcome of co-infection of COVID-19 and tuberculosis: the “cursed duet”
Roland Diel, Neil W. Schluger
European Respiratory Journal (2023) Vol. 62, Iss. 5, pp. 2301881-2301881
Closed Access | Times Cited: 2
Roland Diel, Neil W. Schluger
European Respiratory Journal (2023) Vol. 62, Iss. 5, pp. 2301881-2301881
Closed Access | Times Cited: 2
Tuberculosis Patients During COVID-19 in India (2020–2023): A Brief State-of-the-art View
Jineetkumar Gawad, Mayank Sharma, Neelam Kamble, et al.
Nature Cell and Science (2024) Vol. 2, Iss. 1, pp. 23-27
Open Access
Jineetkumar Gawad, Mayank Sharma, Neelam Kamble, et al.
Nature Cell and Science (2024) Vol. 2, Iss. 1, pp. 23-27
Open Access
Diverse interactions of Mycobacterium tuberculosis infection and of BCG vaccination with SARS-CoV-2
Padmini Salgame, Sri Ram Pentakota, John Carlo M. Malabad, et al.
Frontiers in Tuberculosis (2024) Vol. 2
Open Access
Padmini Salgame, Sri Ram Pentakota, John Carlo M. Malabad, et al.
Frontiers in Tuberculosis (2024) Vol. 2
Open Access
Severe outcomes among adults with TB during COVID-19
T. Jacobs, Erna Morden, Mariette Smith, et al.
Deleted Journal (2024) Vol. 1, Iss. 7, pp. 292-298
Closed Access
T. Jacobs, Erna Morden, Mariette Smith, et al.
Deleted Journal (2024) Vol. 1, Iss. 7, pp. 292-298
Closed Access
Genetically predicted blood metabolites mediate the association between circulating immune cells and severe COVID-19: A Mendelian randomization study
Ning Ai, Yan Zhang, Jing Yang, et al.
Medicine (2024) Vol. 103, Iss. 46, pp. e40509-e40509
Open Access
Ning Ai, Yan Zhang, Jing Yang, et al.
Medicine (2024) Vol. 103, Iss. 46, pp. e40509-e40509
Open Access
Trends and annual percentage changes in tuberculosis mortality estimated by Joinpoint regression and age-period-cohort analyses, Taiwan, 1978–2022
Shu-Yuan Chen
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Shu-Yuan Chen
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
How We Treat Drug-Susceptible Pulmonary Tuberculosis: A Practical Guide for Clinicians
Niccolò Riccardi, Sara Occhineri, Elisa Vanino, et al.
Antibiotics (2023) Vol. 12, Iss. 12, pp. 1733-1733
Open Access | Times Cited: 1
Niccolò Riccardi, Sara Occhineri, Elisa Vanino, et al.
Antibiotics (2023) Vol. 12, Iss. 12, pp. 1733-1733
Open Access | Times Cited: 1
Latent Tuberculosis Infection and COVID-19: Analysis of a Cohort of Patients from Careggi University Hospital (Florence, Italy)
Francesca Mariotti, Francesco Sponchiado, Filippo Lagi, et al.
Infectious Disease Reports (2023) Vol. 15, Iss. 6, pp. 758-765
Open Access
Francesca Mariotti, Francesco Sponchiado, Filippo Lagi, et al.
Infectious Disease Reports (2023) Vol. 15, Iss. 6, pp. 758-765
Open Access
